Skip to Content

Santen Pharmaceutical Co Ltd SNPHF

Morningstar Rating
$9.26 −0.19 (1.99%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SNPHF is trading within a range we consider fairly valued.
Price
$9.29
Fair Value
$62.33
Uncertainty
High
1-Star Price
$18.72
5-Star Price
$8.27
Economic Moat
Ghj
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SNPHF is a good fit for your portfolio.

Trading Information

Previous Close Price
$9.45
Day Range
$9.269.26
52-Week Range
$7.8610.60
Bid/Ask
$9.01 / $9.82
Market Cap
$3.36 Bil
Volume/Avg
196 / 295

Key Statistics

Price/Earnings (Normalized)
12.66
Price/Sales
1.60
Dividend Yield (Trailing)
2.39%
Dividend Yield (Forward)
2.39%
Total Yield
7.59%

Company Profile

Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Mid Growth
Total Number of Employees
1,807

Comparables

Valuation

Metric
SNPHF
4581
4554
Price/Earnings (Normalized)
12.6627.837.53
Price/Book Value
1.590.840.90
Price/Sales
1.602.170.91
Price/Cash Flow
8.1214.483.89
Price/Earnings
SNPHF
4581
4554

Financial Strength

Metric
SNPHF
4581
4554
Quick Ratio
1.844.200.68
Current Ratio
2.465.161.46
Interest Coverage
22.3968.7555.27
Quick Ratio
SNPHF
4581
4554

Profitability

Metric
SNPHF
4581
4554
Return on Assets (Normalized)
7.23%2.57%3.39%
Return on Equity (Normalized)
10.17%3.09%7.02%
Return on Invested Capital (Normalized)
8.56%2.64%4.22%
Return on Assets
SNPHF
4581
4554
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
LLY
Eli Lilly and CoHzgltdymgJhqf$709.2 Bil
JNJ
Johnson & JohnsonKyhymjxFvkmf$351.2 Bil
MRK
Merck & Co IncLzrcdwbjcCkkzn$317.2 Bil
ABBV
AbbVie IncBfxtkynNctr$291.6 Bil
AZN
AstraZeneca PLC ADRNywbryrnlTcdj$210.7 Bil
RHHBY
Roche Holding AG ADRQlsckdbvhnCsh$194.6 Bil
NVS
Novartis AG ADRRwxzfghJstwb$189.7 Bil
PFE
Pfizer IncMdjbkgdGgmd$143.8 Bil
AMGN
Amgen IncMksptbtcxqRqtx$140.9 Bil
SNY
Sanofi SA ADRZpprlnpbTsdk$115.4 Bil

Sponsor Center